OSEBX1 931,36−0,71 %
EQNR337,90−3,43 %
DNB282,70+0,57 %
MOWI198,80−1,68 %
Brent$98,95−2,29 %
Gold$4 744,00+1,06 %
USD/NOK9,2177−0,88 %
EUR/NOK10,8536−0,66 %
SPX7 365,12+0,00 %
NDX28 599,17+0,00 %
LIVE · 10:16 UTC
333257

Nanjing Sinolife United Co Ltd

Miscellaneous Specialty RetailersVerified
Score breakdown
Profitability+12Sentiment+30Missing signals-4
Quality breakdown
Key fields100Profile38Conclusion95AI synthesis40Observations13

Nanjing Sinolife United maintains a strong liquidity position with a current ratio of 2.68 and cash and equivalents of 182.32 million CNY, indicating sufficient short-term assets to cover liabilities [doc:HA-latest]. The company's debt-to-equity ratio of 0.26 suggests a conservative capital structure with limited leverage, supporting financial stability [doc:HA-latest]. Profitability metrics show a return on equity (ROE) of 5.92% and a return on assets (ROA) of 4.09%, which are below the industry median for the Personal Care Products sector. This suggests that the company is generating returns, but at a slower pace compared to its peers [doc:HA-latest]. The company's revenue is primarily derived from the sale of nutritional supplements and packaged health food products, with a focus on cross-border e-commerce. While the input data does not specify geographic revenue concentration, the cross-border nature of its operations implies exposure to international markets, particularly in Asia and potentially North America [doc:HA-latest]. Looking ahead, the company is projected to maintain a stable growth trajectory, with no significant revenue decline or increase expected in the next fiscal year. The current fiscal year revenue of 772.93 million CNY reflects a solid performance, though the absence of historical data limits the ability to assess year-over-year growth [doc:HA-latest]. The company's risk profile is characterized by low liquidity and dilution risk, with no immediate filing-based flags detected. The conservative capital structure and strong cash reserves further mitigate financial risk. However, the company's reliance on cross-border e-commerce exposes it to potential regulatory and geopolitical risks, particularly in international markets [doc:HA-latest]. Recent filings and transcripts do not indicate any major corporate events or strategic shifts. The company continues to focus on its core business of nutritional supplements, with no significant new product launches or market expansions disclosed in the latest available data [doc:HA-latest].

Profile
CompanyNanjing Sinolife United Co Ltd
Ticker3332.HK
SectorConsumer Cyclicals
BusinessRetailers
Industry groupRetailers
IndustryMiscellaneous Specialty Retailers
AI analysis

Business. Nanjing Sinolife United Co Ltd operates in the cross-border e-commerce business of nutritional supplements under the Good Health brand, generating revenue primarily through the sale of products such as Viralex Attack Day & Night, JointPlatinum, and Women’s Multivitamin Gummies [doc:HA-latest].

Classification. The company is classified under the Consumer Cyclicals economic sector, Retailers business sector, and Miscellaneous Specialty Retailers industry, with a confidence level of 0.92 based on verified market data.

Nanjing Sinolife United maintains a strong liquidity position with a current ratio of 2.68 and cash and equivalents of 182.32 million CNY, indicating sufficient short-term assets to cover liabilities [doc:HA-latest]. The company's debt-to-equity ratio of 0.26 suggests a conservative capital structure with limited leverage, supporting financial stability [doc:HA-latest]. Profitability metrics show a return on equity (ROE) of 5.92% and a return on assets (ROA) of 4.09%, which are below the industry median for the Personal Care Products sector. This suggests that the company is generating returns, but at a slower pace compared to its peers [doc:HA-latest]. The company's revenue is primarily derived from the sale of nutritional supplements and packaged health food products, with a focus on cross-border e-commerce. While the input data does not specify geographic revenue concentration, the cross-border nature of its operations implies exposure to international markets, particularly in Asia and potentially North America [doc:HA-latest]. Looking ahead, the company is projected to maintain a stable growth trajectory, with no significant revenue decline or increase expected in the next fiscal year. The current fiscal year revenue of 772.93 million CNY reflects a solid performance, though the absence of historical data limits the ability to assess year-over-year growth [doc:HA-latest]. The company's risk profile is characterized by low liquidity and dilution risk, with no immediate filing-based flags detected. The conservative capital structure and strong cash reserves further mitigate financial risk. However, the company's reliance on cross-border e-commerce exposes it to potential regulatory and geopolitical risks, particularly in international markets [doc:HA-latest]. Recent filings and transcripts do not indicate any major corporate events or strategic shifts. The company continues to focus on its core business of nutritional supplements, with no significant new product launches or market expansions disclosed in the latest available data [doc:HA-latest].
Key takeaways
  • The company maintains a conservative capital structure with a low debt-to-equity ratio of 0.26 and strong liquidity.
  • Return on equity and return on assets are below industry medians, indicating room for improvement in profitability.
  • The company's cross-border e-commerce model exposes it to international market dynamics and regulatory environments.
  • No immediate liquidity or dilution risks are identified, supporting a stable financial outlook.
  • The company's revenue is primarily derived from a limited product portfolio, which may pose concentration risk.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$772.9M
Gross profit$566.2M
Operating income$30.5M
Net income$24.7M
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets$603.5M
Total liabilities$186.5M
Total equity$417.0M
Cash & equivalents$182.3M
Long-term debt$107.2M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$417.0M
Net cash$75.1M
Current ratio2.7
Debt/Equity0.3
ROA4.1%
ROE5.9%
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Retailers · cohort 8 companies
Metric3332Activity
Op margin3.9%9.5% medp25 6.4% · p75 13.1%bottom quartile
Net margin3.2%8.2% medp25 5.0% · p75 11.1%bottom quartile
Gross margin73.3%35.0% medp25 33.0% · p75 44.8%top quartile
R&D / revenue0.4% medp25 0.4% · p75 0.4%
CapEx / revenue3.4% medp25 2.9% · p75 4.6%
Debt / equity26.0%25.8% medp25 3.1% · p75 69.4%above median
Observations
IR observations
Last actual EPS0.16 CNY
Last actual revenue397,064,000 CNY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-03 14:01 UTC#b73c0b65
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 14:03 UTCJob: de162ddd